were first gated by staining with APCH7-Fixable viability stain (lower than 1x103). Live cells were then divided into four groups of analysis: Group 1. From live cells, CD19+ cells were chosen (limit at 1x103) to recognize B cells (CD19+); Group 2. From live cells, CD14b+ cells were chosen (limit at 1x104). Then cells were divided in a double-selection graph including Ly6G-V50 (limit at 1.5x102) and CD11b (limit at 1x102), to recognize neutrophils (Ly6G+CD11b+); Group 3. From live cells, CD14b+ cells were chosen (limit at 1x104). Then cells were divided in a double-selection graph including F4/80-PECF594 (limit at 9x102) and
CD11b (limit at 5X102), to recognize macrophages (F480+CD11b-) and dendritic cells (F480-CD11b+); Group 4. From live cells, lymphocytes were gated in the typical region of these cells, in a FSSC-A/FSC-A graph. Then, from lymphocytes, CD3+ cells were chosen by gating AF700+ cells (limit at 1x103). Afterwards cells were gated into a double selection graph including CD8-BV711 (limit at 4x103) and CD4-BV510 (limit at 5x103). CD4+ and CD8+ T cells were chosen in this graph to be analyzed separately: 4a. CD3+CD4+ T cells were divided in a double selection graph including IFN-BV786 (limit at 1x104) and TNF-AF488 (limit at 1x104) to be CD3+CD4+IFN+ or CD3+CD4+TNF+, 4b. CD3+CD4+ T cells were divided in a double selection graph including IL-12-PE (limit at 1x103) and IL-4-BV421 (limit at 1x104) to be CD3+CD4+IL-12+ or CD3+CD4+IL-4+.
Supplementary method for FACS.
After stimulation with PPD, 1x106 cells per lung were separated and placed into cytometry tubes to wash them with PBS. Then, cells were incubated with 0.5 g of FC purified anti-mouse CD16/CD32 (TONBO, 70-0161) in 100 L of PBS for 10 min at 4 ºC. After this, cells were washed with 1 mL of PBS and viability staining was performed by incubating cells during 15 min with 80 L of 1:79 Flexible Viability staining 750 (BD 565358) diluted in PBS at 4 ºC. Next, for extracellular staining of surface markers, cells were incubated with anti-CD11b-FITC, anti-CD14-PE, anti-F4/80-PECF594, anti-Ly6G-V450, anti-CD3-AF700, anti-CD4-BV510, anti-CD8-BV71 each diluted at 1:99 in 20 L of PBS. To stop this step, cells were washed with 2% bovine serum albumin (Calbiochem, 12660) in PBS and then a permeabilization and fixation step was performed with a buffer set according to manufacturer´s instructions (Invitrogen, 00-5523-00). For intracellular staining of cytokines, fixed and permeabilized cells were incubated for 30 min at 4 ºC with anti-IFN--BV786, anti-TNF--AF488, anti-IL-12-PE and anti-IL-4-BV421 each at 1:99 dilution in PERM buffer from the above-mentioned buffer set. Finally, labeled cells were washed with PERM and resuspended in 500 L of freshly prepared 4% paraformaldehyde. Cells were maintained at 4 ºC in dark up to data obtaining before acquisition by flow cytometry.
Flow cytometry data acquisition was performed in a BD Fortessa cytometer using FACS-DIVA software in the next 24 hours after labeling. Data obtained from 100,000 total cells per lung were analyzed with FlowJo v.10 software to determine the percentages of B cells (CD19+ cells), macrophages (CD11b+ CD14+ F4/80-cells), CD11b+ dendritic cells (CD11b+ CD14+ F4/80+ cells), neutrophils (CD11b+, CD14low Ly6G+), CD3+ CD4+ and CD3+ CD8+ T cells that produced IFN-, TNF-, IL-12, and IL-4 in response to stimulation with PPD. Identification of cell populations is shown in Figure 3A . Four lungs per group/time post-infection were processed.
